Clinical Trial: Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

U.S., Feb. 27 -- ClinicalTrials.gov registry received information related to the study (NCT06847399) titled 'Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder' on Feb. 24.

Brief Summary: The purpose of this study is to assess the efficacy and safety of tirzepatide in adults with obesity and binge-eating disorder, comparing tirzepatide against placebo and lisdexamfetamine dimesylate. All participants will receive guided self-help cognitive behavioral therapy.

Study Start Date: June 01, 2025

Study Type: INTERVENTIONAL

Condition: Obesity and Overweight Binge Eating Disorder

Intervention: DRUG: Tirzepatide

Tirzepatide

DRUG: Lisdexamfetamine Dimesylate

Lisdexamfetamine dimesylate...